Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
WorkClub converts under-used real estate into productive co-working areas and provides an affordable membership for remote workers across London. The company has 500+ members, 800+ guests and 25 WorkClub’s spaces in London. WorkClub has also secured many venues across the UK with Young's, Hippo Inns and more. Furthermore, it is listed as a ‘Top 10 startup to watch’ by TechRound, has 4.8* rating on TrustPilot and, acquired 30 businesses to offer discounted WorkClub memberships to members including ZipCar, PureGym. The company will use the funds to develop WorkClub’s technology and to expand its offering into other key UK cities.
days to go:
Expired
investment:
£342,820
Mindful uses blockchain, artificial intelligence (AI) and video technologies to deliver mental health recovery programmes for 8 to 25-year-olds. With the help of their technology, the therapists work with families and schools to change the way of providing mental health services. The company has a powerful management team experience in business, healthcare and education. Mindful is currently running a pilot project and is signing up schools in the West Midlands. The company is signing partnerships with 6 Multi Academy Trusts with further trust to sign > 50 schools.
days to go:
Expired
investment:
£91,850
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go:
Expired
investment:
£357,179
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go:
Expired
investment:
£451,506
The Stirling Electric Motorcycle Company presents a futuristic motorcycle experience available today! The SEMC "SINATRA" delivers an exhilarating ride, easy maintenance, and the finest ride quality in its category. Whether you're a new, returning, or transitioning rider, enjoy the benefits of electric riding without the complexities and costs of advanced licensing. In numerous regions, motorcycles with up to 11 kilowatts of continuous power have more lenient licensing rules, such as in the UK where an 11kw SINATRA can be legally ridden after completing a one-day basic training course.
days to go:
Expired
investment:
£42,000
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Bua Fit is easy to use, a simple way to book web application for outdoor fitness classes. It eliminates all the trouble by connecting the trainers to clients for group fitness classes and gives the customers a diversity of trainers. The company has been a finalist in The Great British Entrepreneurial Challenge, has a network of 100 trainers and 42% active user rate since launch. With the proceeds, the company will earn more users, more trainers, more revenue, invest in product development and expand the team.
days to go:
Expired
investment:
£205,378
